IL205386A0 - Non - nucleoside reverse transcriptase inhibitors - Google Patents
Non - nucleoside reverse transcriptase inhibitorsInfo
- Publication number
- IL205386A0 IL205386A0 IL205386A IL20538610A IL205386A0 IL 205386 A0 IL205386 A0 IL 205386A0 IL 205386 A IL205386 A IL 205386A IL 20538610 A IL20538610 A IL 20538610A IL 205386 A0 IL205386 A0 IL 205386A0
- Authority
- IL
- Israel
- Prior art keywords
- reverse transcriptase
- transcriptase inhibitors
- nucleoside reverse
- nucleoside
- inhibitors
- Prior art date
Links
- 229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 title 1
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US376907P | 2007-11-20 | 2007-11-20 | |
| PCT/US2008/012774 WO2009067166A2 (en) | 2007-11-20 | 2008-11-14 | Non-nucleoside reverse transcriptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL205386A0 true IL205386A0 (en) | 2010-12-30 |
Family
ID=40336474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL205386A IL205386A0 (en) | 2007-11-20 | 2010-04-27 | Non - nucleoside reverse transcriptase inhibitors |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8404856B2 (https=) |
| EP (1) | EP2222661B1 (https=) |
| JP (1) | JP5539216B2 (https=) |
| KR (1) | KR20100088142A (https=) |
| CN (1) | CN101952274A (https=) |
| AU (1) | AU2008326784B2 (https=) |
| BR (1) | BRPI0820162A2 (https=) |
| CA (1) | CA2705834A1 (https=) |
| IL (1) | IL205386A0 (https=) |
| MX (1) | MX2010005483A (https=) |
| RU (1) | RU2010125220A (https=) |
| WO (1) | WO2009067166A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010026075A1 (en) * | 2008-09-04 | 2010-03-11 | F. Hoffmann-La Roche Ag | Pyridine derivatives as inhibitors of hiv-i reverse transcriptase |
| EP2491033A4 (en) * | 2009-10-20 | 2013-03-13 | Eiger Biopharmaceuticals Inc | AZAINDAZOLES FOR THE TREATMENT OF FLAVIVIRIDAE VIRUS INFECTION |
| SI2924034T1 (sl) * | 2010-03-30 | 2017-05-31 | Merck Canada Inc. | Farmacevtski sestavek, ki obsega nenukleozidni inhibitor reverzne transkriptaze |
| EP2558093A4 (en) * | 2010-04-08 | 2013-10-02 | Merck Sharp & Dohme | PRODRUGS OF HIV INVERTER TRANSCRIPTASE INHIBITOR |
| CA2882947A1 (en) * | 2012-09-26 | 2014-04-03 | Merck Sharp & Dohme Corp. | Crystalline form of a reverse transcriptase inhibitor |
| JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| BR112015012843B8 (pt) * | 2012-12-05 | 2023-04-25 | Merck Sharp & Dohme | Método para sintetizar o composto |
| CA2930585A1 (en) * | 2013-12-04 | 2015-06-11 | Merck Sharp & Dohme Corp. | Process for making reverse transcriptase inhibitors |
| WO2015153304A1 (en) | 2014-04-01 | 2015-10-08 | Merck Sharp & Dohme Corp. | Prodrugs of hiv reverse transcriptase inhibitors |
| CA2957785C (en) | 2014-08-11 | 2023-01-03 | Angion Biomedica Corporation | Cytochrome p450 inhibitors and uses thereof |
| JP2018501279A (ja) | 2014-12-31 | 2018-01-18 | アンギオン バイオメディカ コーポレイション | 疾患を治療するための方法及び薬剤 |
| CN108289931B (zh) * | 2015-09-23 | 2022-10-11 | 默沙东公司 | 4’-取代的核苷逆转录酶抑制剂及其制备 |
| US10189841B2 (en) | 2015-11-20 | 2019-01-29 | Forma Therapeutics, Inc. | Purinones as ubiquitin-specific protease 1 inhibitors |
| JP7111720B2 (ja) | 2016-12-28 | 2022-08-02 | ダート・ニューロサイエンス・エルエルシー | Ｐｄｅ２阻害剤としての置換ピラゾロピリミジノン化合物 |
| CA3120971A1 (en) | 2017-11-27 | 2019-05-31 | Dart Neuroscience, Llc | Substituted furanopyrimidine compounds as pde1 inhibitors |
| CA3122571C (en) * | 2018-12-18 | 2023-08-01 | Merck Sharp & Dohme Corp. | Pyrimidone derivatives as selective cytotoxic agents against hiv infected cells |
| US20220242847A1 (en) * | 2019-05-22 | 2022-08-04 | Merck Sharp & Dohme Corp. | Pyridinone derivatives as selective cytotoxic agents against hiv infected cells |
| CN110066273A (zh) * | 2019-06-05 | 2019-07-30 | 山东大学 | 一种含三氮唑环的单芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用 |
| CN112876409A (zh) * | 2021-01-20 | 2021-06-01 | 都创(上海)医药科技股份有限公司 | 一种2-(5-溴-6-甲氧基吡啶-2-基)乙腈及其衍生物的合成方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99731A0 (en) * | 1990-10-18 | 1992-08-18 | Merck & Co Inc | Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them |
| CA2160928C (en) * | 1993-07-28 | 2005-07-05 | Garry Fenton | Compounds as pde iv and tnf inhibitors |
| BR9909976A (pt) | 1998-04-27 | 2000-12-26 | Centre Nat Rech Scient | Composto, processo para a obtenção de compostos, derivado litiado, composições farmacêuticas, e, processos de tratamento de doenças relacionadas com hiv e de tratamento de infecção de hiv |
| GB9910577D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
| SE9904045D0 (sv) | 1999-11-09 | 1999-11-09 | Astra Ab | Compounds |
| WO2001056990A2 (en) | 2000-02-03 | 2001-08-09 | Eli Lilly And Company | Pyridine derivates as potentiators of glutamate receptors |
| EP1317450B1 (en) | 2000-09-15 | 2006-11-22 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| ATE319706T1 (de) * | 2000-09-19 | 2006-03-15 | Centre Nat Rech Scient | Pyridinon und pyridinethion-derivate mit hiv- hemmenden eigenschaften |
| GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
| RS52392B (sr) * | 2002-02-14 | 2013-02-28 | Pharmacia Corporation | Supstituisani piridinoni kao modulatori p38 map kinaze |
| BRPI0407329A (pt) * | 2003-02-07 | 2006-01-10 | Janssen Pharmaceutica Nv | Derivados de pirimidina para a prevenção de infecção de hiv |
| BRPI0408704A (pt) | 2003-03-24 | 2006-03-07 | Hoffmann La Roche | benzil-piridazinonas como inibidores de transcriptase reversa |
| US20050014774A1 (en) * | 2003-04-28 | 2005-01-20 | Richard Storer | Oxo-pyrimidine compounds |
| US7166738B2 (en) | 2004-04-23 | 2007-01-23 | Roche Palo Alto Llc | Non-nucleoside reverse transcriptase inhibitors |
| DE602005017604D1 (de) | 2004-04-23 | 2009-12-24 | Hoffmann La Roche | Inhibitoren der nicht-nukleosid-inhibitoren der reversen transkriptase |
| TW200843761A (en) * | 2004-10-28 | 2008-11-16 | Shionogi & Co | 3-carbamoyl-2-pyridone derivatives |
| CA2592092A1 (en) * | 2004-12-22 | 2006-06-29 | Pfizer Limited | Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| AR057455A1 (es) | 2005-07-22 | 2007-12-05 | Merck & Co Inc | Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica |
| AU2006303367A1 (en) | 2005-10-19 | 2007-04-26 | F. Hoffmann-La Roche Ag | N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| WO2007045573A1 (en) | 2005-10-19 | 2007-04-26 | F. Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
| US8778977B2 (en) * | 2006-06-30 | 2014-07-15 | Sunesis Pharmaceuticals, Inc. | Pyridinonyl PDK1 inhibitors |
| US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| TW200831085A (en) | 2006-12-13 | 2008-08-01 | Merck & Co Inc | Non-nucleoside reverse transcriptase inhibitors |
| WO2008098143A2 (en) * | 2007-02-08 | 2008-08-14 | Trius Therapeutics | Antimicrobial compounds and methods of use |
-
2008
- 2008-11-14 CN CN2008801168055A patent/CN101952274A/zh active Pending
- 2008-11-14 JP JP2010534947A patent/JP5539216B2/ja not_active Expired - Fee Related
- 2008-11-14 US US12/742,159 patent/US8404856B2/en active Active
- 2008-11-14 CA CA2705834A patent/CA2705834A1/en active Pending
- 2008-11-14 WO PCT/US2008/012774 patent/WO2009067166A2/en not_active Ceased
- 2008-11-14 EP EP08851089.6A patent/EP2222661B1/en not_active Not-in-force
- 2008-11-14 MX MX2010005483A patent/MX2010005483A/es not_active Application Discontinuation
- 2008-11-14 AU AU2008326784A patent/AU2008326784B2/en not_active Ceased
- 2008-11-14 BR BRPI0820162A patent/BRPI0820162A2/pt not_active IP Right Cessation
- 2008-11-14 RU RU2010125220/04A patent/RU2010125220A/ru unknown
- 2008-11-14 KR KR1020107011127A patent/KR20100088142A/ko not_active Withdrawn
-
2010
- 2010-04-27 IL IL205386A patent/IL205386A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010125220A (ru) | 2011-12-27 |
| US8404856B2 (en) | 2013-03-26 |
| MX2010005483A (es) | 2010-06-11 |
| AU2008326784A1 (en) | 2009-05-28 |
| WO2009067166A3 (en) | 2009-07-16 |
| KR20100088142A (ko) | 2010-08-06 |
| CA2705834A1 (en) | 2009-05-28 |
| AU2008326784B2 (en) | 2014-04-24 |
| EP2222661B1 (en) | 2016-04-20 |
| BRPI0820162A2 (pt) | 2019-09-24 |
| CN101952274A (zh) | 2011-01-19 |
| EP2222661A2 (en) | 2010-09-01 |
| JP2011503230A (ja) | 2011-01-27 |
| US20100256181A1 (en) | 2010-10-07 |
| WO2009067166A2 (en) | 2009-05-28 |
| JP5539216B2 (ja) | 2014-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200903395B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| IL205386A0 (en) | Non - nucleoside reverse transcriptase inhibitors | |
| IL200748A0 (en) | Non-nucleoside reverse transcriptse inhibitors | |
| IL196655A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| EP2220091A4 (en) | REVERSE transcriptase inhibitors | |
| ZA201000023B (en) | Novel hiv reverse transcriptase inhibitors | |
| AP2514A (en) | HIV reverse transcriptase inhibitors | |
| HUS1900021I1 (hu) | Nem nukleozid reverz transzkriptáz inhibitorok | |
| EP2076492A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| EP2217069A4 (en) | INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE | |
| ZA201101975B (en) | Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors | |
| TWI372619B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| IL202143A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| IL200886A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| ZA200900071B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| ZA200905761B (en) | Transpiration inhibitor | |
| HK1131985A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| GB0713152D0 (en) | Phosphodlesterase inhibitors | |
| GB0720364D0 (en) | Inhibitor | |
| GB0707495D0 (en) | Novel inhibitors | |
| GB0707632D0 (en) | Novel inhibitors | |
| GB0707499D0 (en) | Novel inhibitors | |
| GB0707498D0 (en) | Novel inhibitors | |
| GB0707488D0 (en) | Novel inhibitors | |
| GB0704589D0 (en) | Novel inhibitors |